Ledger.Open graph →
SEC Form D · Amendment · filed July 25, 2017

Recros Medica, Inc

Offering
$9.0M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Bernard P. Murphy · Seattle, WAExec · DirectorRandall Lunn · LAGUNA HILLS, CAExecAndrew Mills · ALISO VIEJO, CADirectorGregory N. Martin · Los Angeles, CADirectorJohn L. Hadl · Los Angeles, CADirectorMark Padley · NEW YORK, NYExecSirjang Tandon · SIMI VALLEY, CADirectorThomas J. Furphy · Sammamish, WAExec · DirectorWilliam J. Leigh · Seattle, WADirectorObvious Ventures Management Ii, L.L.C · SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗